APN - Aspen Pharmacare Holdings - Further announcement to Aspen shareholders
APN
APN
APN - Aspen Pharmacare Holdings - Further announcement to Aspen shareholders
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN ISIN: ZAE000066692
("Aspen")
Further announcement to Aspen shareholders
Aspen shareholders are referred to the renewal of detailed cautionary
announcement dated 7 July 2010 regarding the confirmed offer (the "Offer") by
Aspen Global Incorporated to acquire the whole of Sigma Pharmaceuticals Limited
("Sigma").
The board of directors of Sigma has advised Aspen that it will work
constructively with Aspen to eliminate the need for the current conditions to
which the Offer is subject. To this extent, Aspen shareholders are referred to
the announcement released today by Sigma, which is available on the ASX website
www.asx.com.au.
Aspen shareholders are advised to continue to exercise caution when dealing in
Aspen shares until a further announcement is made.
Woodmead
12 July 2010
Financial advisor and Sponsor
Investec Corporate Finance and Investec Bank (Australia) Limited
Date: 12/07/2010 09:32:49 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
